Aiforia Technologies Plc announced the release of Aiforia® Studies, a software module that offers AI-assisted image analysis workflow within the framework of Good Laboratory Practices (GLP). Aiforia® Studies is designed especially for pharmaceutical companies and contract research organizations engaged in non-clinical histology studies that need to adhere to GLP guidelines, although its application is not restricted to such studies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 EUR | +1.31% |
|
+2.88% | +33.24% |
Jun. 14 | Finland's Biohit Names Chief Technology Officer | MT |
May. 15 | Aiforia Wins a Framework Agreement to Provide AI Solutions for Fimlab Laboratories in Finland | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.24% | 144M | |
+19.25% | 93.27B | |
+15.90% | 86.11B | |
+63.45% | 61.55B | |
-22.05% | 48.52B | |
+38.19% | 48.21B | |
-23.72% | 46.24B | |
+82.30% | 42.44B | |
-4.72% | 26.52B | |
-11.35% | 24.65B |
- Stock Market
- Equities
- AIFORIA Stock
- News Aiforia Technologies Oyj
- Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow